XML 25 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
The Southern California Regional Gamma Knife Center (Tables)
 9 Months Ended
Sep. 30, 2022
Neuro Partners LLC and CGK [Member]  
Schedule of Equity Method Investments [Line Items]  
Equity Method Investment Summarized Financial Information

The following tables present the aggregation of summarized financial information of NeuroPartners LLC and CGK:
 

NeuroPartners LLC and CGK Condensed Combined Income Statement Information
 
   
Nine Months Ended
 
    September 30,  
   
2022
    
2021
  
             
Patient Revenue
  
$
242,000
    
$
463,000
  
                 
Net (loss) income
  
$
(215,000
)
  
$
12,000
  
                 
USNC’s equity in loss of NeuroPartners, LLC and CGK
  
$
(110,000
)
  
$
(22,000
)
 
   
Three Months Ended
 
    September 30,  
   
2022
    
2021
  
             
Patient revenue
  
$
(36,000
)
  
$
127,000
  
                 
Net (loss) income
  
$
(188,000
)
  
$
(15,000
)
                 
USNC’s equity in loss of NeuroPartners LLC and CGK
  
$
(83,000
)
  
$
(15,000
)

NeuroPartners LLC and CGK Condensed Combined Balance Sheet Information
   
September 30,
    
December 31,
  
    2022     2021  
             
Current assets
  
$
226,000
    
$
299,000
  
                 
Noncurrent assets
    
358,000
      
294,000
  
                 
Total assets
  
$
584,000
    
$
593,000
  
                 
Current liabilities
  
$
942,000
    
$
564,000
  
                 
Noncurrent liabilities
     -       -  
                 
Equity
    
(358,000
)
    
29,000
  
                 
Total liabilities and equity
  
$
584,000
    
$
593,000